A discordant histological risk classification in preoperative and operative biopsy in endometrial cancer is reflected in metastatic risk and prognosis

European Journal of Cancer

Volumn 49, Issue 3, 2013, Pages 625-632

  Werner, H M J ^a,b   Trovik, J ^a,b   Marcickiewicz, J ^c,d   Tingulstad, S ^e   Staff, A C ^f,g   Engh, M E ^h,i   Oddenes, K ⁱ   Rokne, J A ^j   Tjugum, J ^k   Lode, M S ^l   Amant, F ^m   Salvesen, H B ^a,b  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d Hallands Hospital   (Sweden)

^e TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^f ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^g UNIVERSITY OF OSLO   (Norway)

^h AKERSHUS UNIVERSITY HOSPITAL   (Norway)

ⁱ HAUGESUND HOSPITAL   (Norway)

^j VESTFOLD HOSPITAL TRUST   (Norway)

^k Department of Obstetrics and Gynecology   (Norway)

^l Alesund Hospital   (Norway)

^m UNIVERSITY OF LEUVEN   (Belgium)

more..

Author keywords

Endometrial carcinoma; Histology; Metastasis; Preoperative biopsy; Prognosis

Indexed keywords

ANTINEOPLASTIC AGENT;

AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; DISEASE SPECIFIC SURVIVAL; ENDOMETRIUM BIOPSY; ENDOMETRIUM CANCER; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; HYSTERECTOMY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METASTASIS; PREOPERATIVE EVALUATION; PRIORITY JOURNAL;

ADULT; AGED; BIOPSY; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYSTERECTOMY; LYMPHATIC METASTASIS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK;

EID: 84872683421     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2012.09.006     Document Type: Article

References (28)

1. F. Amant, P. Moerman, P. Neven, D. Timmerman, E. Van Limbergen, and I. Vergote Endometrial cancer Lancet 366 2005 491 505
2. V.M. Abeler, and K.E. Kjorstad Endometrial adenocarcinoma in Norway. A study of a total population Cancer 67 1991 3093 3103
3. C.P. Morrow, B.N. Bundy, and R.J. Kurman Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study Gynecol Oncol 40 1991 55 65
4. G.H. Eltabbakh, J. Shamonki, and S.L. Mount Surgical stage, final grade, and survival of women with endometrial carcinoma whose preoperative endometrial biopsy shows well-differentiated tumors Gynecol Oncol 99 2005 309 312
5. M. Frumovitz, D.K. Singh, and L. Meyer Predictors of final histology in patients with endometrial cancer Gynecol Oncol 95 2004 463 468
6. B. Lampe, R. Kurzl, and P. Hantschmann Reliability of tumor typing of endometrial carcinoma in prehysterectomy curettage Int J Gynecol Pathol 14 1995 2 6
7. M.M. Leitao Jr., S. Kehoe, and R.R. Barakat Accuracy of preoperative endometrial sampling diagnosis of FIGO grade 1 endometrial adenocarcinoma Gynecol Oncol 111 2008 244 248
8. M.M. Leitao Jr., S. Kehoe, and R.R. Barakat Comparison of D&C and office endometrial biopsy accuracy in patients with FIGO grade 1 endometrial adenocarcinoma Gynecol Oncol 113 2009 105 108
9. D.M. Boruta, P.A. Gehrig, and P.A. Groben Uterine serous and grade 3 endometrioid carcinomas: is there a survival difference? Cancer 101 2004 2214 2221
10. M. Llaurado, A. Ruiz, and B. Majem Molecular bases of endometrial cancer: new roles for new actors in the diagnosis and the therapy of the disease Mol Cell Endocrinol 25 2012 244 255
11. R.A. Soslow Endometrial carcinomas with ambiguous features Semin Diagn Pathol 27 2010 261 273
12. Molecular Markers in Treatment in Endometrial Cancer (MoMaTEC). Available from: http://clinicaltrialsgov/ct2/show/NCT00598845?term=MoMaTec&rank=1.
13. W. Creasman Revised FIGO staging for carcinoma of the endometrium Int J Gynaecol Obstet 105 2009 109
14. S. Pecorelli Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium Int J Gynaecol Obstet 105 2009 103 104
15. J. Trovik, E. Wik, and I.M. Stefansson Stathmin overexpression identifies high-risk patients and lymph node metastasis in endometrial cancer Clin Cancer Res 17 2011 3368 3377
16. H.O. Critchley, P. Warner, A.J. Lee, S. Brechin, J. Guise, and B. Graham Evaluation of abnormal uterine bleeding: comparison of three outpatient procedures within cohorts defined by age and menopausal status Health Technol Assess 8 2004 iii iv 1-139
17. F.P. Dijkhuizen, B.W. Mol, H.A. Brolmann, and A.P. Heintz The accuracy of endometrial sampling in the diagnosis of patients with endometrial carcinoma and hyperplasia: a meta-analysis Cancer 89 2000 1765 1772
18. J.V. Bokhman Two pathogenetic types of endometrial carcinoma Gynecol Oncol 15 1983 10 17
19. A.N. Fader, D. Starks, and P.A. Gehrig An updated clinicopathologic study of early-stage uterine papillary serous carcinoma (UPSC) Gynecol Oncol 115 2009 244 248
20. B.M. Slomovitz, T.W. Burke, and P.J. Eifel Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases Gynecol Oncol 91 2003 463 469
21. S. Chafe, L. Honore, R. Pearcey, and V. Capstick An analysis of the impact of pathology review in gynecologic cancer Int J Radiat Oncol Biol Phys 48 2000 1433 1438
22. J.S. Kwon, J.A. Francis, F. Qiu, M.M. Weir, and H.C. Ettler When is a pathology review indicated in endometrial cancer? Obstet Gynecol 110 2007 1224 1230
23. W.G. McCluggage Problematic areas in the reporting of endometrial carcinomas in hysterectomy specimens Diagn Histopathol 15 2009 571 581
24. A.G. Nayar, P.A. Cross, J.N. Bulmer, S. Deen, and A. El-Sherif Comparison of examination of the entire uterine cervix with routine cervical sampling in hysterectomy specimens from women with endometrial cancer J Clin Pathol 61 2008 621 622
25. C.L. Trimble, J. Kauderer, and R. Zaino Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study Cancer 106 2006 812 819
26. W.G. McCluggage, L. Hirschowitz, G.E. Wilson, E. Oliva, R.A. Soslow, and R.J. Zaino Significant variation in the assessment of cervical involvement in endometrial carcinoma: an interobserver variation study Am J Surg Pathol 35 2011 289 294
27. C.L. Creutzberg, W.L. van Putten, and P.C. Koper Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma Lancet 355 2000 1404 1411
28. R.A. Nout, V.T. Smit, and H. Putter Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial Lancet 375 2010 816 823